261 related articles for article (PubMed ID: 23357351)
1. Predictors of health-related quality of life and adjustment to prostate cancer during active surveillance.
Bellardita L; Rancati T; Alvisi MF; Villani D; Magnani T; Marenghi C; Nicolai N; Procopio G; Villa S; Salvioni R; Valdagni R
Eur Urol; 2013 Jul; 64(1):30-6. PubMed ID: 23357351
[TBL] [Abstract][Full Text] [Related]
2. Living with untreated prostate cancer: predictors of quality of life.
Bellardita L; Villa S; Valdagni R
Curr Opin Urol; 2014 May; 24(3):311-7. PubMed ID: 24637318
[TBL] [Abstract][Full Text] [Related]
3. Prostate cancer active surveillance and health-related quality of life: results of the Finnish arm of the prospective trial.
Vasarainen H; Lokman U; Ruutu M; Taari K; Rannikko A
BJU Int; 2012 Jun; 109(11):1614-9. PubMed ID: 22044485
[TBL] [Abstract][Full Text] [Related]
4. Prospective study of men's psychological and decision-related adjustment after treatment for localized prostate cancer.
Steginga SK; Occhipinti S; Gardiner RA; Yaxley J; Heathcote P
Urology; 2004 Apr; 63(4):751-6. PubMed ID: 15072894
[TBL] [Abstract][Full Text] [Related]
5. Long-term Psychological and Quality-of-life Effects of Active Surveillance and Watchful Waiting After Diagnosis of Low-risk Localised Prostate Cancer.
Egger SJ; Calopedos RJ; O'Connell DL; Chambers SK; Woo HH; Smith DP
Eur Urol; 2018 Jun; 73(6):859-867. PubMed ID: 28851582
[TBL] [Abstract][Full Text] [Related]
6. Time, symptom burden, androgen deprivation, and self-assessed quality of life after radical prostatectomy or watchful waiting: the Randomized Scandinavian Prostate Cancer Group Study Number 4 (SPCG-4) clinical trial.
Johansson E; Bill-Axelson A; Holmberg L; Onelöv E; Johansson JE; Steineck G;
Eur Urol; 2009 Feb; 55(2):422-30. PubMed ID: 18783877
[TBL] [Abstract][Full Text] [Related]
7. Multidisciplinary care and pursuit of active surveillance in low-risk prostate cancer.
Aizer AA; Paly JJ; Zietman AL; Nguyen PL; Beard CJ; Rao SK; Kaplan ID; Niemierko A; Hirsch MS; Wu CL; Olumi AF; Michaelson MD; D'Amico AV; Efstathiou JA
J Clin Oncol; 2012 Sep; 30(25):3071-6. PubMed ID: 22851571
[TBL] [Abstract][Full Text] [Related]
8. Evaluating peer support for prostate cancer: the Prostate Cancer Peer Support Inventory.
Steginga SK; Pinnock C; Gardner M; Gardiner RA; Dunn J
BJU Int; 2005 Jan; 95(1):46-50. PubMed ID: 15663527
[TBL] [Abstract][Full Text] [Related]
9. Psychosocial and demographic predictors of quality of life in a large sample of cancer patients.
Parker PA; Baile WF; de Moor Cd; Cohen L
Psychooncology; 2003 Mar; 12(2):183-93. PubMed ID: 12619150
[TBL] [Abstract][Full Text] [Related]
10. Quality of life of patients with Takayasu's arteritis.
Abularrage CJ; Slidell MB; Sidawy AN; Kreishman P; Amdur RL; Arora S
J Vasc Surg; 2008 Jan; 47(1):131-6; discussion 136-7. PubMed ID: 18178464
[TBL] [Abstract][Full Text] [Related]
11. Psychosocial factors associated with quality of life in allogeneic stem cell transplant patients prior to transplant.
Pillay B; Lee SJ; Katona L; Burney S; Avery S
Psychooncology; 2014 Jun; 23(6):642-9. PubMed ID: 24375571
[TBL] [Abstract][Full Text] [Related]
12. How does active surveillance for prostate cancer affect quality of life? A systematic review.
Bellardita L; Valdagni R; van den Bergh R; Randsdorp H; Repetto C; Venderbos LD; Lane JA; Korfage IJ
Eur Urol; 2015 Apr; 67(4):637-45. PubMed ID: 25454617
[TBL] [Abstract][Full Text] [Related]
13. Biopsy features associated with prostate cancer progression in active surveillance patients: comparison of three statistical models.
Iremashvili V; Manoharan M; Rosenberg DL; Soloway MS
BJU Int; 2013 Apr; 111(4):574-9. PubMed ID: 22564446
[TBL] [Abstract][Full Text] [Related]
14. Factors affecting health-related quality of life in prostate cancer patients.
Mickevičienė A; Vanagas G; Ulys A; Jievaltas M; Smailytė G; Padaiga Ž
Scand J Urol Nephrol; 2012 Jun; 46(3):180-7. PubMed ID: 22375530
[TBL] [Abstract][Full Text] [Related]
15. Psychological aspects of active surveillance.
van den Bergh RC; Korfage IJ; Bangma CH
Curr Opin Urol; 2012 May; 22(3):237-42. PubMed ID: 22357407
[TBL] [Abstract][Full Text] [Related]
16. Insurance and quality of life in men with prostate cancer: data from the Cancer of the Prostate Strategic Urological Research Endeavor.
Sadetsky N; Lubeck DP; Pasta DJ; Latini DM; DuChane J; Carroll PR
BJU Int; 2008 Mar; 101(6):691-7. PubMed ID: 18291018
[TBL] [Abstract][Full Text] [Related]
17. Mental health in men treated for early stage prostate carcinoma: a posttreatment, longitudinal quality of life analysis from the Cancer of the Prostate Strategic Urologic Research Endeavor.
Litwin MS; Lubeck DP; Spitalny GM; Henning JM; Carroll PR
Cancer; 2002 Jul; 95(1):54-60. PubMed ID: 12115317
[TBL] [Abstract][Full Text] [Related]
18. Anxiety in the management of localised prostate cancer by active surveillance.
Anderson J; Burney S; Brooker JE; Ricciardelli LA; Fletcher JM; Satasivam P; Frydenberg M
BJU Int; 2014 Nov; 114 Suppl 1():55-61. PubMed ID: 25070423
[TBL] [Abstract][Full Text] [Related]
19. Prostate cancer diagnosis is associated with an increased risk of erectile dysfunction after prostate biopsy.
Helfand BT; Glaser AP; Rimar K; Zargaroff S; Hedges J; McGuire BB; Catalona WJ; McVary KT
BJU Int; 2013 Jan; 111(1):38-43. PubMed ID: 22639942
[TBL] [Abstract][Full Text] [Related]
20. Predictors of distress and quality of life in patients undergoing cancer therapy: impact of treatment type and decisional role.
Hack TF; Pickles T; Ruether JD; Weir L; Bultz BD; Mackey J; Degner LF
Psychooncology; 2010 Jun; 19(6):606-16. PubMed ID: 19557823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
